Decision-analytical modelling in health-care economic evaluations

[1] Sun X.(2006)Methods for economic evaluation of marketed medicines II: Conducting primary economic evaluation Chin J Evid Based Med 6 218-223

[2] Orlewska E.(2000)Modelling in health economic evaluation: What is its place? What is its value? Pharmacoeconomics 17 445-459

[3] Li Y.P.(1997)Modelling in economic evaluation: an unavoidable fact of life Health Econ 6 217-227

[4] Cheng G.(2000)Modelling in health economic evaluation. What is its place? What is its value? Pharmacoeconomics 17 445-459

[5] Yang H.(1997)The interactive use of economic evaluation as part of the process of health technology assessment J Health Serv Res Policy 2 26-30

[6] Brennan A.(2003)The role of modelling in prioritising and planning clinical trials Health Technol Assess 7 1-125

[7] Akehurst R.(2003)Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation Health Econ 12 837-848

[8] Buxton M.J.(2002)The cost-effectiveness of alternative therapeutic strategies for the management of chronic hepatitis B in Poland Value Health 5 405-421

[9] Drummond M.F.(2006)What is the most cost-effective treatment for 1 to 2-cm bulbar urethral strictures: societal approach using decision analysis Urology 67 889-893

[10] Van Hout B.A.(2002)Development of a decision-analytic model of stroke care in the United States and Europe Value Health 5 82-97

[1] Sun X.(2006)Methods for economic evaluation of marketed medicines II: Conducting primary economic evaluation Chin J Evid Based Med 6 218-223

[2] Orlewska E.(2000)Modelling in health economic evaluation: What is its place? What is its value? Pharmacoeconomics 17 445-459

[3] Li Y.P.(1997)Modelling in economic evaluation: an unavoidable fact of life Health Econ 6 217-227

[4] Cheng G.(2000)Modelling in health economic evaluation. What is its place? What is its value? Pharmacoeconomics 17 445-459

[5] Yang H.(1997)The interactive use of economic evaluation as part of the process of health technology assessment J Health Serv Res Policy 2 26-30

[6] Brennan A.(2003)The role of modelling in prioritising and planning clinical trials Health Technol Assess 7 1-125

[7] Akehurst R.(2003)Alternative decision modelling techniques for the evaluation of health care technologies: Markov processes versus discrete event simulation Health Econ 12 837-848

[8] Buxton M.J.(2002)The cost-effectiveness of alternative therapeutic strategies for the management of chronic hepatitis B in Poland Value Health 5 405-421

[9] Drummond M.F.(2006)What is the most cost-effective treatment for 1 to 2-cm bulbar urethral strictures: societal approach using decision analysis Urology 67 889-893

[10] Van Hout B.A.(2002)Development of a decision-analytic model of stroke care in the United States and Europe Value Health 5 82-97